About Empire Genomics
Empire Genomics is a company based in Buffalo (United States) founded in 2006 was acquired by Biocare Medical in November 2022. It operates as a Direct-to-Consumer (D2C), and Professional Services. Empire Genomics has raised $3.3 million across 7 funding rounds from investors including Biocare Medical, NIH and HHS. The company has 14 employees as of December 31, 2022. Empire Genomics has completed 1 acquisition, including ID Labs. Empire Genomics offers products and services including FISH Probes, Custom FISH Probe Design, and FISH Ancillaries. Empire Genomics operates in a competitive market with competitors including Neogen, Parse Biosciences, Qiagen, Biofidelity and Novogene Corporation, among others.
- Headquarter Buffalo, United States
- Employees 14 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Empire Genomics, A Biocare Medical Company
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.3 M (USD)
in 7 rounds
-
Latest Funding Round
$1.75 M (USD), Series A
May 20, 2016
-
Investors
Biocare Medical
& 6 more
-
Employee Count
14
as on Dec 31, 2022
- Investments & Acquisitions
-
Acquired by
Biocare Medical
(Nov 22, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Empire Genomics
Empire Genomics offers a comprehensive portfolio of products and services, including FISH Probes, Custom FISH Probe Design, and FISH Ancillaries. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
FISH probes are provided for clinical diagnostics.
Custom FISH probes are designed per client needs.
Ancillary reagents are offered for FISH testing accuracy.
Funding Insights of Empire Genomics
Empire Genomics has successfully raised a total of $3.3M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $1.75 million completed in May 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series A — $1.8M
- First Round First Round
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2016 | Amount | Series A - Empire Genomics | Valuation | Broadoak Capital Partners | |
| Feb, 2016 | Amount | Series A - Empire Genomics | Valuation | Rand Capital |
|
| Nov, 2014 | Amount | Seed - Empire Genomics | Valuation | Rand Capital , Z80 Labs |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Empire Genomics
Empire Genomics has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Biocare Medical, NIH and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early & Growth stage VC Firm investing primarily in the US
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Empire State Development is focused on economic growth in New York.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Empire Genomics
Empire Genomics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include ID Labs. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Custom molecular biology and immunologic research services are provided.
|
1989 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Empire Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Empire Genomics Comparisons
Competitors of Empire Genomics
Empire Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neogen, Parse Biosciences, Qiagen, Biofidelity and Novogene Corporation, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing
|
|
| domain | founded_year | HQ Location |
RNA-sequencing transcriptome kits for health data analysis are developed.
|
|
| domain | founded_year | HQ Location |
Products and reagents for molecular diagnostic assays are supplied.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostic assays are developed for target DNA sequence detection.
|
|
| domain | founded_year | HQ Location |
Genomic services and solutions with NGS expertise are provided.
|
|
| domain | founded_year | HQ Location |
Proprietary reagents for single-cell genetic analysis are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Empire Genomics
Frequently Asked Questions about Empire Genomics
When was Empire Genomics founded?
Empire Genomics was founded in 2006 and raised its 1st funding round 2 years after it was founded.
Where is Empire Genomics located?
Empire Genomics is headquartered in Buffalo, United States. It is registered at Buffalo, New York, United States.
Is Empire Genomics a funded company?
Empire Genomics is a funded company, having raised a total of $3.3M across 7 funding rounds to date. The company's 1st funding round was a Seed of $1.25M, raised on Jun 01, 2008.
How many employees does Empire Genomics have?
As of Dec 31, 2022, the latest employee count at Empire Genomics is 14.
What does Empire Genomics do?
Empire Genomics is engaged in offering reliable FISH testing solutions for clinical diagnostics and research applications. A comprehensive catalog of probes and ancillary reagents is provided, leveraging an extensive BAC library from the Human Genome Project. Solutions are created for a wide range of applications, from discovery and development to routine testing in clinical labs. Rapid turnaround times are ensured, with next-day shipping for in-stock products and custom designs completed in as little as two weeks. The company is dedicated to serving as a trusted partner in the healthcare and biotechnology sectors, focusing on precision and quality in diagnostics.
Who are the top competitors of Empire Genomics?
Empire Genomics's top competitors include Neogen, Novogene Corporation and Qiagen.
What products or services does Empire Genomics offer?
Empire Genomics offers FISH Probes, Custom FISH Probe Design, and FISH Ancillaries.
How many acquisitions has Empire Genomics made?
Empire Genomics has made 1 acquisition, including ID Labs.
Who are Empire Genomics's investors?
Empire Genomics has 7 investors. Key investors include Biocare Medical, NIH, HHS, Broadoak Capital Partners, and Rand Capital.